NasdaqGS - Nasdaq Real Time Price USD

Anavex Life Sciences Corp. (AVXL)

8.25
-0.31
(-3.62%)
At close: May 9 at 4:00:00 PM EDT
8.35
+0.10
+(1.21%)
After hours: May 9 at 7:15:04 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
9/30/2024
9/30/2023
9/30/2022
9/30/2021
Total Revenue
0
0
0
0
0
Operating Expense
55,004
52,802
55,731
50,986
41,948
Operating Income
-55,004
-52,802
-55,731
-50,986
-41,948
Net Non Operating Interest Income Expense
6,706
7,320
5,555
947
26
Other Income Expense
1,807
2,480
2,678
2,419
4,281
Pretax Income
-46,491
-43,002
-47,498
-47,620
-37,641
Tax Provision
--
0
7
358
268
Net Income Common Stockholders
-46,491
-43,002
-47,505
-47,978
-37,909
Diluted NI Available to Com Stockholders
-46,491
-43,002
-47,505
-47,978
-37,909
Basic EPS
-0.55
-0.52
-0.60
-0.62
-0.54
Diluted EPS
-0.55
-0.52
-0.60
-0.62
-0.54
Basic Average Shares
84,150.09
83,468.05
79,787.60
76,909.99
69,802.96
Diluted Average Shares
84,150.09
83,468.05
79,787.60
76,909.99
69,802.96
Total Operating Income as Reported
-55,091
-52,877
-55,756
-50,986
-42,002
Total Expenses
55,004
52,802
55,731
50,986
41,948
Net Income from Continuing & Discontinued Operation
-46,491
-43,002
-47,505
-47,978
-37,909
Normalized Income
-46,187
-43,191
-47,473.40
-47,263.84
-37,714.82
Interest Income
6,706
7,320
6,519
947
26
Interest Expense
--
0
964
0
0
Net Interest Income
6,706
7,320
5,555
947
26
EBIT
-45,204
-43,002
-46,534
-47,620
-37,641
EBITDA
-45,204
-43,002
-46,534
-47,620
-37,641
Net Income from Continuing Operation Net Minority Interest
-46,491
-43,002
-47,505
-47,978
-37,909
Total Unusual Items Excluding Goodwill
-304
189
-40
-904
-266
Total Unusual Items
-304
189
-40
-904
-266
Normalized EBITDA
-44,900
-43,191
-46,494
-46,716
-37,375
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
-8.40
-189.84
-71.82
9/30/2021 - 8/2/2006

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

ANVS Annovis Bio, Inc.
1.5300
-4.37%
 
SAVA Cassava Sciences, Inc.
1.7700
+4.12%
 
CGTX Cognition Therapeutics, Inc.
0.3011
-8.76%
 
AXSM Axsome Therapeutics, Inc.
107.76
-1.01%
 
VNDA Vanda Pharmaceuticals Inc.
3.9500
-6.40%
 
ALT Altimmune, Inc.
5.59
-3.62%
 
INMB INmune Bio, Inc.
6.97
-1.69%
 
AUPH Aurinia Pharmaceuticals Inc.
8.00
-1.36%
 
CADL Candel Therapeutics, Inc.
4.8100
+1.05%
 
CAPR Capricor Therapeutics, Inc.
6.34
-9.04%